Easy Trip Plann. (EASEMYTRIP)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Near-zero leverage: D/E of 0.04 provides a financial cushion in a cyclical downturn.
• ROCE of 20.89% suggests the core operations generate a reasonable return on capital deployed.
• Promoter holding of 47.72% aligns management interests with minority shareholders.
• Latest quarter is still profitable: ₹3 Cr net profit on ₹152 Cr sales, albeit on a thin margin.
• Sales growth remains positive at 0.72%, showing no outright revenue collapse.

Concerns

• P/E of 119.30 and PEG of 165.69 imply an extreme valuation relative to current earnings and growth.
• Profit growth fell 82.61% and ROE is just 6.04%, so shareholder-level returns are weak.
• Piotroski F-Score of 4/9 indicates deteriorating fundamental health.
• No dividend yield at 0.00%, so investors need all returns to come from price appreciation.

AI Analysis

When I study Easy Trip Plann, I do not start with the share price. I start with the economics of the business. At ₹7.73, the market cap is ₹3,135 Cr. The latest quarter earned only ₹3 Cr on sales of ₹152 Cr—a net margin of about 2%. Over the last twelve months, profit growth collapsed by 82.61% while sales grew by just 0.72%. That is not a compounding machine; it is a travel-related cyclicals business that is currently earning very little. Benjamin Graham taught me to insist on a margin of safety. Here I find the opposite: P/E at 119.30 and P/B at 3.96 against book value of ₹1.95. A PEG ratio of 165.69 is not a valuation, it is a warning sign. The balance sheet does have one virtue: debt/equity of only 0.04. That low leverage gives the company financial endurance, and ROCE of 20.89% shows the operating capital is being used reasonably well. But the return shareholders actually receive, ROE, is just 6.04%—well below what I demand. Promoter holding of 47.72% is encouraging because owner and public shareholders are aligned, but with a zero dividend yield, every return must come from price appreciation. The Piotroski score of 4/9 reinforces my concerns: the financial health has deteriorated. In this case, the low 52-week price of ₹5.77 versus the current ₹7.73 tells me the market has already repriced part of the bad news, but the shares are still not cheap on current earnings. I would not classify this as a fast grower or stalwart. It is a cyclical, and until I see a sustained recovery in margins and positive earnings momentum, I will keep this on my watchlist, not in my portfolio. For a retail investor, waiting and preserving capital is part of value investing.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer